Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,081

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Antileukemic Effect of Chronic Graft-versus-Host Disease: Contribution to Improved Survival after Allogeneic Marrow Transplantation

Weiden, Paul L., Sullivan, Keith M., Flournoy, Nancy, Storb, Rainer, Thomas, E. Donnall, The Seattle Marrow Transplant Team·1981·New England Journal of Medicine

Abstract

ALLOGENEIC marrow transplantation is being used with increasing frequency in the treatment of acute leukemia.1 2 3 4 Recurrent leukemia is an uncommon cause of therapeutic failure in patients with acute nonlymphoblastic leukemia who receive transplants while the disease is in first remission,1 , 3 , 4 but recurrence is a major cause of failure in patients with acute nonlymphoblastic leukemia or acute lymphoblastic leukemia who receive transplants with the disease in relapse or in a second or subsequent remission. 2 , 3 , 5 Attempts to decrease the rate of leukemic relapse with more vigorous chemoradiotherapy conditioning regimens have generally been unsuccessful.2 , 6 , 7 However, we previously reported that the rate of leukemic . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm198106183042507

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 1,081

Metadata

Authors
Weiden, P. L., Sullivan, K. M., Flournoy, N., Storb, R., Thomas, E. D., & The Seattle Marrow Transplant Team
Venue
New England Journal of Medicine
Published
1981-06-18
Volume
304
Issue
25
Pages
1529-1533
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2067480394
Cited by
1,081
References
1
FWCI
19.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antileukemic Effect of Chronic Graft-versus-Host Disease: Contribution to Improved Survival after Allogeneic Marrow Transplantation. https://app.cochat.ai/papers/10.1056/nejm198106183042507
The paper
Weiden, P. L., Sullivan, K. M., Flournoy, N., Storb, R., Thomas, E. D., & The Seattle Marrow Transplant Team. (1981). Antileukemic Effect of Chronic Graft-versus-Host Disease: Contribution to Improved Survival after Allogeneic Marrow Transplantation. New England Journal of Medicine. https://doi.org/10.1056/nejm198106183042507

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.